BRAF and central nervous system cancer: Next, we tested the impact of BRAF-inhibition on the expression of the respective ETS-factors and found that only ETS1 expression, but not expression of GABPA or the different GABPB splice variants, were significantly and consistently downregulated throughout all BRAFV600E-mutated glioma.